• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗性血液成分单采术治疗抗中性粒细胞胞浆抗体相关性急进性肾小球肾炎和肺出血肾炎综合征

The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis.

作者信息

Apaydin Suheyla

机构信息

University of Health Sciences, Medical Faculty, Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Center, Nephrology Department, Istanbul, Turkey.

出版信息

Transfus Apher Sci. 2018 Feb;57(1):8-12. doi: 10.1016/j.transci.2018.02.007. Epub 2018 Feb 20.

DOI:10.1016/j.transci.2018.02.007
PMID:29503131
Abstract

Therapeutic plasma aphresis (plasmapheresis) is one form of treatment that is frequently used in practice of Nephrology. Plasmapheresis is the most important part of the therapies for Goodpasture's syndrome and anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis which are causes of rapidly progressive glomerulonephritis. The reason why the effectiveness of plasmapheresis therapy cannot be clearly demonstrated in renal involvement in these diseases is that it does not appear to be possible to recruit an adequate number of patients and plasmapheresis is not effective in advanced disease if early treatment is not initiated.

摘要

治疗性血浆置换术(血浆置换)是肾脏病学实践中常用的一种治疗方式。血浆置换是治疗肺出血肾炎综合征和抗中性粒细胞胞浆抗体(ANCA)相关性血管炎的最重要治疗手段,这两种疾病是快速进展性肾小球肾炎的病因。血浆置换疗法在这些疾病的肾脏受累方面疗效无法得到明确证实,原因在于似乎难以招募到足够数量的患者,而且如果不早期开始治疗,血浆置换在疾病晚期是无效的。

相似文献

1
The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis.治疗性血液成分单采术治疗抗中性粒细胞胞浆抗体相关性急进性肾小球肾炎和肺出血肾炎综合征
Transfus Apher Sci. 2018 Feb;57(1):8-12. doi: 10.1016/j.transci.2018.02.007. Epub 2018 Feb 20.
2
[ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis].[抗中性粒细胞胞浆抗体(ANCA)和抗髓鞘碱性蛋白(MBG)双阳性血管炎:临床及治疗特异性的最新进展以及与两种以人名命名的血管炎的比较]
Rev Med Interne. 2020 Jan;41(1):21-26. doi: 10.1016/j.revmed.2019.10.334. Epub 2019 Dec 12.
3
Apheresis to treat systemic vasculitis.用血细胞分离术治疗系统性血管炎。
Joint Bone Spine. 2018 Mar;85(2):177-183. doi: 10.1016/j.jbspin.2017.06.001. Epub 2017 Jun 7.
4
A "double-seropositive" Vasculitis for antiglomerular basement membrane antibodies and antineutrophil cytoplasmic antibody, and multiple myeloma, all three with simultaneous diagnosis of renal involvement, common pathophysiology, or pure coincidence? first case in the World.一例同时诊断为抗肾小球基底膜抗体和抗中性粒细胞胞浆抗体“双阳性”血管炎、多发性骨髓瘤且均累及肾脏的病例:是共同病理生理机制,还是纯属巧合?世界首例。
Saudi J Kidney Dis Transpl. 2019 Jul-Aug;30(4):953-959. doi: 10.4103/1319-2442.265473.
5
[An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].[新月体性肾小球肾炎起病的Goodpasture综合征中双阳性髓过氧化物酶-抗中性粒细胞胞浆抗体(MPO-ANCA)和抗肾小球基底膜抗体的治疗经验]
Nihon Jinzo Gakkai Shi. 1998 Nov;40(8):591-6.
6
[Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].[血浆置换在免疫性肾脏疾病中的作用。1050次血浆置换治疗完成后的经验]
Orv Hetil. 2011 Jul 10;152(28):1110-9. doi: 10.1556/OH.2011.29155.
7
[Review on anti-glomerular basement membrane disease or Goodpasture's syndrome].[抗肾小球基底膜病或古德帕斯彻综合征综述]
Rev Med Interne. 2020 Jan;41(1):14-20. doi: 10.1016/j.revmed.2019.10.338. Epub 2019 Nov 24.
8
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.与单阳性患者相比,同时出现抗中性粒细胞胞浆抗体(ANCA)和抗肾小球基底膜(GBM)抗体双阳性的患者具有不同的肾脏存活率、复发频率和结局。
Kidney Int. 2017 Sep;92(3):693-702. doi: 10.1016/j.kint.2017.03.014. Epub 2017 May 12.
9
Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.肾抗中性粒细胞胞浆抗体(ANCA)相关血管炎患者抗髓过氧化物酶抗中性粒细胞胞浆抗体(ANCA)水平升高:与复发风险的关联
J Rheumatol. 2015 Oct;42(10):1853-60. doi: 10.3899/jrheum.141622. Epub 2015 Sep 15.
10
Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.抗中性粒细胞胞质抗体相关性血管炎患者抗 Goodpasture 自身抗原线性表位的抗体。
Clin Rheumatol. 2017 Sep;36(9):2087-2094. doi: 10.1007/s10067-017-3692-8. Epub 2017 May 26.

引用本文的文献

1
IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.器官特异性自身免疫病中的 IgG4 自身抗体:综述类别转换、产生抗体的细胞和特异性免疫治疗。
Front Immunol. 2022 Mar 24;13:834342. doi: 10.3389/fimmu.2022.834342. eCollection 2022.
2
Therapeutic apheresis in kidney transplantation: An updated review.肾移植中的治疗性血液成分单采:最新综述。
World J Transplant. 2019 Oct 28;9(6):103-122. doi: 10.5500/wjt.v9.i6.103.